Checking how well the Padua score predicts blood clot risk after chest surgery
Tests how accurately a risk score predicts blood clots in thoracic surgery patients.
Key facts
- Who runs it
- Al-Nahrain University
- Where
- Iraq1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Padua Prediction Score for VTE Risk in Thoracic Surgery Patients
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 20 Apr 2025
- Expected to end
- 15 Jul 2027
- Type of study
- Observational
- Record updated
- 17 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having chest (thoracic) surgery who stay in hospital. It studies how well the Padua Prediction Score predicts blood clots in the veins.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Thoracic surgery patients staying in hospital for over 3 days.
- Earlier treatment
- People must have had a Padua Prediction Score check before surgery. People taking any blood-thinning (anticoagulation) treatment cannot join.
- Biomarker or test result
- People must have had a D-dimer blood test after surgery.
Main reasons for not taking part
- A blood clot in the leg veins or lungs (pulmonary embolism) before the study
- Severe bleeding disorders, such as hemophilia or advanced liver disease
- Taking any blood-thinning treatment
- Pregnant, or gave birth within the last six weeks
- Missing key medical or lab data, or unable to attend follow-up
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients who have undergone preoperative Padua Prediction Score assessment
- Inpatients with a hospital stay over 3 days
- Written informed consent obtained from patients or their legal guardians
- Availability for postoperative follow-up to assess outcomes like LEVT development or related complications
Who cannot take part
- receiving any anticoagulation therapy for any reason
- Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease)
- Incomplete Data: missing essential clinical or laboratory data
- Preexisting LEVT or pulmonary embolism
- patients who did not undergo a postoperative D-dimer test
- Pregnancy: pregnant women or those within six weeks postpartum
- Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols
This trial is currently available in Iraq.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to assess the predictive accuracy of the Padua Prediction Score (PPS) for venous thromboembolism (VTE) risk in thoracic surgery patients.
Read full original descriptionShow less
The study aims to answer the following question:
Does the PPS provide a more accurate prediction of VTE risk?
Participants will:
Have their VTE risk assessed using the PPS during their hospital admission.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of the Padua Prediction Score for Venous Thromboembolism Risk Stratification in Thoracic Surgery Patients: Insights From a Single-Center Cohort Study in Iraq
- Plain-language title
- Checking how well the Padua score predicts blood clot risk after chest surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 17 September 2026